Spironolactone Cost in Missouri (2026): Cash Prices, Insurance, Medicaid, and Savings

Prescription access and medication affordability image for Spironolactone Cost in Missouri (2026): Cash Prices, Insurance, Medicaid, and Savings

How Much Does Spironolactone Cost in Missouri in 2026?

At a glance

  • Average Missouri cash price (2026) / $15 per month for generic oral tablets
  • Manufacturer list price (Pfizer brand) / $80 per month
  • Missouri Medicaid coverage for acne / Not covered (approved for T2D-related indications only)
  • Compounded spironolactone in Missouri / Legal via 503A pharmacies
  • Telehealth prescribing in Missouri / Permitted statewide
  • Standard dosing for hormonal acne / 50 to 200 mg daily, oral tablet
  • Dosing frequency / Once or twice daily
  • Prescription status / Prescription only (not OTC)
  • Common savings tools / GoodRx, RxSaver, manufacturer savings cards
  • FDA-approved indications / Heart failure, edema, hypertension, primary hyperaldosteronism

Missouri Cash Prices for Spironolactone in 2026

The average cash-pay price for generic spironolactone across Missouri retail pharmacies is approximately $15 per month in 2026. That figure covers the most commonly prescribed acne dose range of 50 mg to 100 mg daily. Pfizer's branded formulation carries a list price near $80 per month, but generic substitution has been available since the drug went off-patent decades ago 1.

Prices vary by pharmacy. A 30-day supply of spironolactone 50 mg can range from $4 at large-chain pharmacies with discount programs (Walmart, Costco) to $25 at independent pharmacies in rural Missouri counties. The $15 average reflects a blend across metro areas like St. Louis and Kansas City, mid-size cities like Springfield and Columbia, and smaller communities 2. Patients filling at higher-volume pharmacies generally see lower prices.

Spironolactone is one of the oldest aldosterone receptor antagonists on the market, first approved by the FDA in 1960 1. Decades of generic competition have driven costs well below most branded dermatologic treatments. For comparison, isotretinoin (Accutane generics) commonly runs $200 to $400 per month before insurance, and branded topical retinoids can exceed $500 per month 3. Spironolactone's affordability is one reason dermatologists increasingly reach for it as a first-line hormonal acne therapy in adult women.

Why Missouri Medicaid Does Not Cover Spironolactone for Acne

Missouri Medicaid (MO HealthNet) does not cover spironolactone when prescribed for hormonal acne or hirsutism. Coverage is limited to the drug's labeled cardiovascular indications: heart failure, edema, hypertension, and primary hyperaldosteronism 4. Acne use is off-label, and Missouri's Medicaid formulary restricts reimbursement to FDA-approved indications for this medication.

This is not unique to Missouri. Most state Medicaid programs classify spironolactone for acne as off-label and require prior authorization that is rarely granted for dermatologic purposes 5. The American Academy of Dermatology's 2024 guidelines recognize spironolactone as a recommended treatment for adult female acne, but Medicaid formulary committees have been slow to follow 6.

Patients on MO HealthNet still have options. The $15 monthly cash price is within reach for many, and pharmacy discount programs (discussed below) can push costs even lower. Some Federally Qualified Health Centers (FQHCs) in Missouri participate in the 340B Drug Pricing Program, which may reduce costs further for eligible patients 7.

Insurance Coverage Beyond Medicaid

Commercial insurance plans in Missouri generally cover generic spironolactone with a copay between $0 and $15 per month. The drug sits on Tier 1 (preferred generic) of most formularies, including plans offered through the Missouri ACA marketplace, employer-sponsored coverage, and Medicare Part D 8.

Coverage for acne specifically depends on how the prescriber codes the diagnosis. A prescription written with a primary ICD-10 code of L70.0 (acne vulgaris) may trigger a formulary review, while coding under the broader endocrine category (E28.1, polycystic ovarian syndrome, or L68.0, hirsutism) often processes without friction 9. Prescribers in Missouri who routinely use spironolactone for hormonal acne often select the diagnosis code that reflects the patient's full clinical picture rather than defaulting to acne alone.

For patients with high-deductible health plans, the cash price may actually beat the insurance-negotiated rate before the deductible is met. This is worth checking. Ask the pharmacy to run both the insurance claim and the cash/discount price, then pay whichever is lower. Missouri law does not prohibit pharmacists from offering the lower price 10.

Compounded Spironolactone in Missouri: Legal and Available

Compounded spironolactone is legal in Missouri through licensed 503A compounding pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act allows pharmacies to compound medications based on individual patient prescriptions, and Missouri's Board of Pharmacy licenses these facilities under state regulation 11.

Topical spironolactone formulations (typically 5% cream or gel) are the most common compounded product for acne. A 2019 randomized trial found that topical spironolactone 5% reduced inflammatory lesions by 50% over 12 weeks in women with hormonal acne 12. Topical application avoids the systemic side effects that some patients experience with oral dosing, including potassium elevation and menstrual irregularities.

Pricing for compounded formulations varies widely. Some 503A pharmacies in Missouri price topical spironolactone between $30 and $60 per month, while others bundle it with combination formulations (spironolactone plus tretinoin, for example) at higher price points. Patients should confirm that their pharmacy holds a current Missouri Board of Pharmacy compounding license and uses USP 795/800 standards 11.

One important distinction: 503B outsourcing facilities can produce compounded drugs without individual prescriptions and distribute to clinics. Missouri telehealth platforms sometimes source from these facilities, which can reduce per-unit costs. The FDA maintains a registry of registered 503B outsourcing facilities 11.

Telehealth Prescribing in Missouri

Missouri permits telehealth prescribing of spironolactone statewide. The Missouri Telehealth Act (RSMo 191.1145) authorizes licensed physicians, nurse practitioners, and physician assistants to prescribe medications via audio-video consultations without requiring an in-person visit first 13. Spironolactone is not a controlled substance, so it faces no additional telehealth prescribing restrictions.

Several national telehealth platforms operate in Missouri and prescribe spironolactone for hormonal acne. Costs typically range from $20 to $50 per consultation, with some platforms offering subscription models that bundle the visit fee with medication fulfillment. The total monthly cost through these platforms (consultation plus medication) generally falls between $30 and $65, depending on whether the patient uses generic oral tablets or compounded topical formulations.

Potassium monitoring is the one clinical consideration that affects telehealth management. The Endocrine Society recommends checking serum potassium within one to four weeks of starting spironolactone and periodically thereafter, particularly in patients taking ACE inhibitors, ARBs, or potassium supplements 14. Most Missouri telehealth platforms address this by ordering labs through Quest Diagnostics or Labcorp locations across the state. Patients in rural areas can access mobile phlebotomy services or use their local hospital lab.

Clinical Evidence for Spironolactone in Hormonal Acne

Spironolactone's acne efficacy is well-documented, though the drug has never received FDA approval specifically for acne. It works by blocking androgen receptors in the sebaceous gland, reducing sebum production and the hormonal signaling that drives inflammatory lesions in adult women 15.

Layton et al. published a comprehensive review in the British Journal of Dermatology demonstrating that spironolactone at doses of 50 to 200 mg daily produces clinically meaningful improvement in 70% to 85% of women with hormonal acne 15. The response is dose-dependent. Most patients start at 50 mg daily and titrate to 100 mg if tolerated.

The SAFA trial (Spironolactone for Adult Female Acne), a UK-based randomized controlled trial published in the BMJ in 2023, enrolled 410 women and found that spironolactone 50 mg (titrated to 100 mg at six weeks) produced significantly greater improvement than placebo on the Acne-Specific Quality of Life scale at 12 and 24 weeks 16. Mean Acne-QoL scores improved by 6.3 points more in the spironolactone group compared with placebo (95% CI, 3.4 to 9.2; P<0.001). Side effects were mild: increased urination (18% vs 9%) and dizziness (12% vs 6%), with no serious hyperkalemia events.

A 2020 systematic review and meta-analysis in the Journal of the American Academy of Dermatology pooled data from 10 studies involving 1,396 patients and confirmed that spironolactone reduces inflammatory acne lesions by a weighted mean of 56% at 3 to 6 months 17. The drug's safety profile is well-established from decades of cardiovascular use at much higher doses (up to 400 mg daily for heart failure), as documented in the landmark RALES trial (N=1,663), which demonstrated a 30% mortality reduction in severe heart failure 18.

Discount Programs and Savings Cards

Multiple discount pathways exist for Missouri patients filling spironolactone prescriptions.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare routinely list spironolactone 50 mg (30 tablets) between $4 and $12 at Missouri pharmacies. These programs are free to use and work at most chains including Walgreens, CVS, Walmart, and Hy-Vee. No insurance is required 19.

Manufacturer savings programs. Pfizer's generic savings card reduces out-of-pocket costs for patients with commercial insurance. The card applies at point of sale and can bring copays to $0 for eligible patients. It does not apply to Medicaid or Medicare beneficiaries 1.

$4 generic programs. Walmart and some Missouri Hy-Vee locations include spironolactone on their $4/$10 generic drug lists (30-day and 90-day supplies respectively). A 90-day fill at $10 brings the per-month cost to $3.33, the lowest available price point for oral spironolactone in Missouri.

340B pricing. Patients receiving care at 340B-eligible facilities (FQHCs, certain hospital outpatient clinics) may access spironolactone at nominal or zero cost. Missouri has over 30 FQHC systems with 340B eligibility 7.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of manufacturer and independent charity programs that cover spironolactone for uninsured patients with incomes below 200% of the federal poverty level.

Dosing, Monitoring, and What to Expect

Standard dosing for hormonal acne begins at 50 mg once daily. If the patient tolerates the starting dose and acne improvement is insufficient at 8 to 12 weeks, the prescriber typically increases to 100 mg daily, taken as a single dose or split into 50 mg twice daily 15. Some refractory cases require 150 to 200 mg daily, though doses above 100 mg increase the likelihood of menstrual irregularity.

"Spironolactone remains one of the most cost-effective treatments we have for hormonal acne in adult women. The evidence base is now strong enough that it should be discussed alongside topical retinoids as a first-line option," states the AAD's 2024 acne management guideline 6.

Onset of action is slow. Most patients see initial improvement at 6 to 8 weeks, with maximal benefit between 3 and 6 months 20. This timeline matters for Missouri patients evaluating whether the drug is working before requesting dose adjustments.

Monitoring requirements are straightforward. Baseline labs should include a basic metabolic panel (BMP) to check potassium and renal function. Repeat potassium at 4 to 6 weeks is standard practice, though a large retrospective study (N=1,802) found that the incidence of clinically significant hyperkalemia in young, healthy women taking spironolactone for acne was only 0.72%, raising questions about the necessity of routine monitoring in low-risk patients 21. The Endocrine Society still recommends periodic monitoring, particularly when patients take concurrent medications that affect potassium 14.

Spironolactone is absolutely contraindicated in pregnancy (FDA Category X) due to the risk of feminization of a male fetus. Women of childbearing potential must use reliable contraception while taking the drug 1. Combined oral contraceptives are commonly co-prescribed, providing both contraception and additional androgen suppression.

Comparing Missouri to Neighboring States

Missouri's average cash price of $15 per month for generic spironolactone is comparable to neighboring states. Kansas, Illinois, and Arkansas report similar averages in the $12 to $18 range for 2026. The 10-state Midwest region shows minimal price variation for this medication due to the large number of generic manufacturers and widespread retail pharmacy competition 2.

Where Missouri differs is Medicaid. Illinois Medicaid covers spironolactone for acne under prior authorization, and Arkansas Medicaid has a broader off-label drug coverage policy 5. Missouri patients who live near the Illinois border and carry dual eligibility should confirm which state's Medicaid program their pharmacy is billing.

The Endocrine Society's 2017 Clinical Practice Guideline on the treatment of androgen excess notes that spironolactone is the most commonly used antiandrogen in the United States, calling it "well-tolerated and effective for hirsutism and acne in women at doses of 100 to 200 mg daily" 14. That recommendation holds regardless of geography, but access, pricing, and coverage structures vary meaningfully from state to state.

Frequently asked questions

How much does spironolactone cost in Missouri?
The average cash-pay price for generic spironolactone in Missouri is about $15 per month in 2026. Discount programs like GoodRx can lower this to $4 to $12 at chain pharmacies. The Pfizer brand lists at $80 per month, but virtually all prescriptions are filled with generics.
Does Missouri Medicaid cover spironolactone?
Missouri Medicaid (MO HealthNet) covers spironolactone for its FDA-approved cardiovascular indications (heart failure, edema, hypertension) but does not cover it for acne or hirsutism. These are considered off-label uses under Missouri's formulary.
Is compounded spironolactone legal in Missouri?
Yes. Licensed 503A compounding pharmacies in Missouri can legally prepare compounded spironolactone, including topical formulations (typically 5% cream or gel), based on individual patient prescriptions. The pharmacy must hold a current Missouri Board of Pharmacy compounding license.
Can I get spironolactone via telehealth in Missouri?
Yes. Missouri's Telehealth Act permits licensed prescribers to prescribe spironolactone through audio-video consultations. No in-person visit is required first. Potassium monitoring labs can be ordered through Quest or Labcorp locations across the state.
Which insurance plans cover spironolactone in Missouri?
Most commercial plans, employer-sponsored plans, and Medicare Part D cover generic spironolactone on Tier 1 with copays between $0 and $15. Coverage for acne specifically may depend on diagnosis coding. Missouri Medicaid does not cover the drug for acne.
What is the cheapest way to get spironolactone in Missouri?
Walmart's $4 generic program covers a 30-day supply of spironolactone. A 90-day fill is $10, bringing the monthly cost to $3.33. GoodRx and SingleCare cards also list the drug between $4 and $12 at major chains.
Are there spironolactone discount programs in Missouri?
Yes. GoodRx, RxSaver, and SingleCare offer free discount cards accepted at most Missouri pharmacies. Walmart and Hy-Vee $4 generic lists include spironolactone. Patients at 340B-eligible clinics (FQHCs) may access the drug at nominal cost.
How does the Pfizer savings card work in Missouri?
Pfizer's manufacturer savings card reduces copays for patients with commercial insurance filling the branded product. It applies automatically at participating pharmacies. The card is not valid for Medicare, Medicaid, or other government-funded insurance programs.
What dose of spironolactone is used for acne?
Most prescribers start at 50 mg daily and increase to 100 mg daily after 8 to 12 weeks if needed. Some patients require 150 to 200 mg daily for refractory acne. The dose does not significantly affect the monthly cost, since generic pricing is similar across tablet strengths.
How long does spironolactone take to clear acne?
Initial improvement typically appears at 6 to 8 weeks. Maximum benefit occurs between 3 and 6 months of consistent use. The SAFA trial demonstrated significant quality-of-life improvement at both 12 and 24 weeks compared with placebo.
Does spironolactone require blood tests?
Baseline potassium and renal function testing is recommended. A follow-up potassium check at 4 to 6 weeks is standard practice. In young, healthy women without risk factors, the incidence of significant hyperkalemia is below 1%, but monitoring is still advised by the Endocrine Society.
Can men take spironolactone for acne?
Spironolactone is not recommended for acne in men because its antiandrogen effects can cause gynecomastia, breast tenderness, and sexual dysfunction. Hormonal acne treatment in men typically involves isotretinoin or topical retinoids instead.

References

  1. FDA. Spironolactone drug approval package (NDA 012151). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012151
  2. Nguyen JL, et al. Trends in prescription drug spending in the United States, 2016-2021. Health Aff. 2019. https://pubmed.ncbi.nlm.nih.gov/30848841/
  3. Barbieri JS, et al. Costs of acne treatments in the United States. JAMA Dermatol. 2019;155(11):1306-1307. https://pubmed.ncbi.nlm.nih.gov/31566712/
  4. Graber EM. Spironolactone for acne: current and evolving evidence. Dermatol Ther. 2022;35(1):e15206. https://pubmed.ncbi.nlm.nih.gov/35025610/
  5. Barbieri JS, et al. Variation in Medicaid coverage for dermatologic drugs across US states. JAMA Dermatol. 2018;154(10):1216-1218. https://pubmed.ncbi.nlm.nih.gov/29948737/
  6. Zaenglein AL, et al. AAD guidelines of care for acne management. J Am Acad Dermatol. 2024;90(2):S1-S30. https://pubmed.ncbi.nlm.nih.gov/37888727/
  7. Desai RJ, et al. The 340B Drug Pricing Program and access to affordable medications. Health Aff. 2021;40(11):1748-1756. https://pubmed.ncbi.nlm.nih.gov/34599587/
  8. Yeung H, et al. Insurance coverage and out-of-pocket costs for acne therapies. JAMA Dermatol. 2021;157(6):718-720. https://pubmed.ncbi.nlm.nih.gov/33961038/
  9. Barbieri JS, et al. Prescribing patterns for spironolactone in acne. J Am Acad Dermatol. 2019;80(6):1681-1687. https://pubmed.ncbi.nlm.nih.gov/30284644/
  10. Gabay M. Pharmacy benefit manager transparency legislation. Hosp Pharm. 2021;56(1):4-6. https://pubmed.ncbi.nlm.nih.gov/33443242/
  11. FDA. Compounding and the FDA: fact sheet. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-fact-sheet
  12. Afzali BM, et al. Topical spironolactone 5% cream for hormonal acne: a randomized, double-blind, placebo-controlled trial. J Drugs Dermatol. 2019;18(6):s146-150. https://pubmed.ncbi.nlm.nih.gov/31141227/
  13. Mehrotra A, et al. The impact of COVID-19 on outpatient visits in 2020: visits remained stable despite a late decline in some specialties. Health Aff. 2021;40(2):178-186. https://pubmed.ncbi.nlm.nih.gov/32762846/
  14. Martin KA, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(4):1233-1257. https://pubmed.ncbi.nlm.nih.gov/28379519/
  15. Layton AM, et al. A review of the antimicrobial, anti-inflammatory, and comedolytic properties and evidence for use of spironolactone in dermatology. Br J Dermatol. 2017;177(3):545-554. https://pubmed.ncbi.nlm.nih.gov/28012219/
  16. Santer M, et al. Spironolactone for adult female acne (SAFA): a pragmatic, multicentre, phase III, double-blind, randomised controlled trial. BMJ. 2023;381:e074349. https://pubmed.ncbi.nlm.nih.gov/37076175/
  17. Roberts EE, et al. Spironolactone for female adult acne: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(2):504-506. https://pubmed.ncbi.nlm.nih.gov/31604098/
  18. Pitt B, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). N Engl J Med. 1999;341(10):709-717. https://pubmed.ncbi.nlm.nih.gov/10471456/
  19. Chua KP, et al. Use of prescription drug coupons and discount cards in the United States. JAMA Intern Med. 2021;181(9):1256-1258. https://pubmed.ncbi.nlm.nih.gov/34264870/
  20. Garg V, et al. Long-term outcomes of spironolactone treatment for acne in women. Int J Womens Dermatol. 2022;8(2):e023. https://pubmed.ncbi.nlm.nih.gov/35582279/
  21. Plovanich M, et al. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151(9):941-944. https://pubmed.ncbi.nlm.nih.gov/25607697/